Summary
BIOTHIMAX is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €19,341 and a net result of €356,797. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 10% of 9,743 sector peers (NACE 64, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-01
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-01
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
11-09
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- Board meeting, 01-07-2024
- Registered-office move, Karbeelstraat 2,8510 Marke
2023
20-12
NBB filing
Annual accounts filed
financial year 2023 · micro format
23-01
Gazette deed
Appointments: Tom Tytgat (statutory director) and Melissa Desmet (statutair opvolgend bestuurder)Capital conversion · Amendment of the articles8 facts ▸
Gazette deed
Appointments: Tom Tytgat (statutory director) and Melissa Desmet (statutair opvolgend bestuurder)
Capital conversion · Amendment of the articles8 facts ▸
- General meeting, 13-01-2023
- Other provision, “behoud rechtsvorm en aanneming nieuwe statuten, aanneming volledig nieuwe statuten” (deed in Dutch)
- Capital conversion, “beschikbare inbreng” (deed in Dutch)
- Amendment of the articles
- Director appointment, Tom Tytgat (statutory director)
- Director appointment, Melissa Desmet (statutair opvolgend bestuurder)
- Board composition, Tom Tytgat (statutory director)
- Board composition, Melissa Desmet (statutair opvolgend bestuurder)
2022
13-12
NBB filing
Annual accounts filed
financial year 2022 · micro format
2021
16-12
NBB filing
Annual accounts filed
financial year 2021 · micro format
30-06
Financial
Highest result from 2019 to 2025net €395,044 ▲6.3%
Net result €395,044, the highest in the series.
30-06
Financial
Liquidity more than 5 timescurrent ratio 15.26
Current ratio from 2.74 to 15.26; short-term debt falls from €133,110 to €44,072.
30-06
Financial
Equity above €1mequity €1.1m ▲53.8%
A profit in every financial year since 2019 builds equity to €1.1m.
2020
18-12
NBB filing
Annual accounts filed
financial year 2020 · micro format
13-11
NBB filing
Annual accounts filed
financial year 2019 · micro format · 287 days late
Show earlier events
13-11
NBB filing
Annual accounts filed
financial year 2018 · micro format · 652 days late
30-06
Financial
Liquidity more than quadruplescurrent ratio 2.74
Current ratio from 0.64 to 2.74; short-term debt falls from €136,787 to €133,110.
30-06
Financial
Equity above €500,000equity €734,409 ▲102%
A profit in every financial year since 2019 builds equity to €734,409.
2018
28-02
NBB filing
Annual accounts filed
financial year 2017 · micro format · 28 days late
2017
28-02
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 28 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
2 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.